Mifepristone priming and subsequent misoprostol for second trimester medical abortion in women with previous caesarean delivery.

Published in: The Australian & New Zealand journal of obstetrics & gynaecology (2023)

Mifepristone-misoprostol abortion in women with prior CS is generally safe but associated with an increased risk of procedural complications. Lowering of the misoprostol dosage with prior CS may reduce uterine rupture, although this hypothesis requires ongoing research.

Keyphrases

healthcare
preterm birth
risk factors
pregnant women